PYXIS ONCOLOGY INC (PYXS)
US7473241013 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -57.36M | -73.79M | -120.72M | -75.98M | -12.83M | |||
| Depreciation Amortization | 3.12M | 1.93M | 710.00K | 650.00K | 470.00K | |||
| Change In Working Capital | -7.47M | -11.66M | 4.50M | 6.68M | 2.29M | |||
| Taxes Paid | N/A | 48.00K | 20.00K | N/A | N/A | |||
| Other non cash items | 8.07M | 12.82M | 26.17M | 33.33M | -10.00K | |||
| OPERATING CASH FLOW | -53.63M | -70.71M | -89.34M | -35.33M | -10.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -233.00K | -6.73M | -6.40M | -540.00K | -1.48M | |||
| Other Investing Activity | -8.04M | -98.12M | 0.00 | -50.00K | N/A | |||
| INVESTING CASH FLOW | -8.27M | -104.85M | -6.40M | -590.00K | -1.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 59.52M | 6.24M | 180.00K | 304.04M | 40.00K | |||
| Other Financing Activity | -263.00K | -313.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 59.26M | 5.93M | 180.00K | 304.04M | 40.00K | |||
| CHANGE IN CASH | -2.65M | -169.63M | -95.56M | 268.12M | -11.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.63M | -70.71M | -89.34M | -35.33M | -10.08M | |||
| Capital Expenditure | -233.00K | -6.73M | -6.40M | -540.00K | -1.48M | |||
| FREE CASH FLOW | -53.86M | -77.44M | -95.74M | -35.87M | -11.56M | |||
All data in USD